BX-U001

Human umbilical cord-derived mesenchymal stem cells · Baylx Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for BX-U001, covering 2025-12-23 to 2025-12-29. Get the full timeline:

Most recent: Clinical Trial Update: Use of hUC-MSC Product (BX-U001) for the Treatment of COVID-19 With ARDS [Phase 1, Phase 2]